Murine Liver Metastasis Model Using L5178Y-ML Lymphoma and the Effect of Antitumor Agents on the Metastasis

Overview

Journal Jpn J Cancer Res

Specialty Oncology

Date 1988 Nov 1

PMID 3147276

Citations 9

Authors

Y Watanabe

A Okura

K Naito

M Kobayashi

Affiliations

Soon will be listed here.

Abstract

A reproducible tumor model for liver metastasis has been developed from murine L5178Y lymphoma line by sequential cycles of subcutaneous inoculation of liver tumor cells, that were originally generated in livers of female (BALB/c x DBA/2)F1 mice by injecting the parental cells into the tail vein. This variant (L5178Y-ML) metastasized predominantly to the liver after intravenous or subcutaneous injection. The livers of the animals killed 9 days after intravenous implantation of 5 x 10(5) tumor cells were about 3 times the weight of control livers. All tumor-bearing mice died 10 to 12 days after inoculation. Subcutaneous implantation of L5178Y-ML in the side flank of mice induced metastatic nodules spontaneously in the livers. The tumor cells proliferated more in livers than in the implanted sites, compared with the parental L5178Y cells. The effects of 5-fluorouracil, mitomycin C, cis-platinum and doxorubicin on the liver metastasis of L5178Y-ML were examined at subtoxic doses; 5-fluorouracil was the most effective in both inhibiting the tumor growth in livers and prolonging the survival period of mice. This model provides a useful tool for the experimental therapy of hepatic tumors in mice.

Citing Articles

Antimetastatic effect of a novel indolocarbazole (NB-506) on IMC-HM murine tumor cells metastasized to the liver.

Arakawa H, Matsumoto H, Morita M, Sasaki M, Taguchi K, Okura A Jpn J Cancer Res. 1996; 87(5):518-23.

PMID: 8641990 PMC: 5921114. DOI: 10.1111/j.1349-7006.1996.tb00254.x.

Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs.

Saiki I, Yoneda J, Kobayashi H, Igarashi Y, Komazawa H, Ishizaki Y Jpn J Cancer Res. 1993; 84(3):326-35.

PMID: 8486531 PMC: 5919152. DOI: 10.1111/j.1349-7006.1993.tb02874.x.

Deoxyribonuclease treatment prevents blood-borne liver metastasis of cutaneously transplanted tumour cells in mice.

Sugihara S, Yamamoto T, Tanaka H, Kambara T, Hiraoka T, Miyauchi Y Br J Cancer. 1993; 67(1):66-70.

PMID: 8427781 PMC: 1968215. DOI: 10.1038/bjc.1993.10.

Inhibition of tumor metastasis by Arg-Gly-Asp-Ser (RGDS) peptide conjugated with sulfated chitin derivative, SCM-chitin-RGDS.

Komazawa H, Saiki I, Nishikawa N, Yoneda J, Yoo Y, Kojima M Clin Exp Metastasis. 1993; 11(6):482-91.

PMID: 8222396 DOI: 10.1007/BF00054939.

Inhibitory effect of antimetastatic fusion polypeptide of human fibronectin on tumor cell adhesion to extracellular matrices.

Matsumoto Y, Saiki I, Makabe T, Yoneda J, Murata J, Kimizuka F Jpn J Cancer Res. 1991; 82(10):1130-8.

PMID: 1955380 PMC: 5918258. DOI: 10.1111/j.1349-7006.1991.tb01767.x.

References

Bosslet K, Schirrmacher V . High-frequency generation of new immunoresistant tumor variants during metastasis of a cloned murine tumor line (ESb). Int J Cancer. 1982; 29(2):195-202. DOI: 10.1002/ijc.2910290214. View

Kerbel R, Twiddy R, Robertson D . Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain. Int J Cancer. 1978; 22(5):583-94. DOI: 10.1002/ijc.2910220513. View

WEISS L . Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency. Int J Cancer. 1980; 25(3):385-92. DOI: 10.1002/ijc.2910250313. View

Yoshida E, Komiyama K, Naito K, Watanabe Y, Takamiya K, Okura A . Antitumor effect of kazusamycin B on experimental tumors. J Antibiot (Tokyo). 1987; 40(11):1596-604. DOI: 10.7164/antibiotics.40.1596. View

Schirrmacher V, Shantz G, Clauer K, Komitowski D, Zimmermann H, Lohmann-Matthes M . Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer. 1979; 23(2):233-44. DOI: 10.1002/ijc.2910230215. View

Murayama K, Levery S, Schirrmacher V, Hakomori S . Qualitative differences in position of sialylation and surface expression of glycolipids between murine lymphomas with low metastatic (Eb) and high metastatic (ESb) potentials and isolation of a novel disialoganglioside (GD1 alpha) from Eb cells. Cancer Res. 1986; 46(3):1395-402. View

Parr I . Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. Br J Cancer. 1972; 26(3):174-82. PMC: 2008478. DOI: 10.1038/bjc.1972.24. View

Hart I, Talmadge J, Fidler I . Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res. 1981; 41(4):1281-7. View

Shearman P, Longenecker B . Selection for virulence and organ-specific metastasis of herpesvirus-transformed lymphoma cells. Int J Cancer. 1980; 25(3):363-9. DOI: 10.1002/ijc.2910250310. View

10.

Parks R . Organ-specific metastasis of a transplantable reticulum cell sarcoma. J Natl Cancer Inst. 1974; 52(3):971-3. DOI: 10.1093/jnci/52.3.971. View

11.

Burkart V, Malter M, Suss R, Friedrich E . Liver as a tumor-cell-killing organ. Immunol Commun. 1984; 13(1):77-81. DOI: 10.3109/08820138409025451. View

12.

Yoshida E, Nishimuta Y, Naito K, Watanabe Y, Tomisaka S, Okura A . The effect of kazusamycin on the growth of murine solid tumors and their spontaneous metastasis. J Antibiot (Tokyo). 1987; 40(3):391-3. DOI: 10.7164/antibiotics.40.391. View

13.

Brunson K, Nicolson G . Selection and biologic properties of malignant variants of a murine lymphosarcoma. J Natl Cancer Inst. 1978; 61(6):1499-503. View

14.

Altevogt P, Schirrmacher V . New plasma membrane proteins expressed by a high metastatic variant of a chemically induced tumor. Eur J Cancer Clin Oncol. 1984; 20(9):1155-62. DOI: 10.1016/0277-5379(84)90125-1. View

15.

Altevogt P, Fogel M, Dennis J, Robinson P, Schirrmacher V . Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res. 1983; 43(11):5138-44. View

16.

Larizza L, Schirrmacher V, Graf L, PFLUGER E, Stohr M . Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Int J Cancer. 1984; 34(5):699-707. DOI: 10.1002/ijc.2910340518. View

17.

Lafreniere R, Rosenberg S . A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J Natl Cancer Inst. 1986; 76(2):309-22. View

18.

Koike A, Nakazato H, Moore G . The fate of Ehrlich cells injected into the portal system. Cancer. 1963; 16:716-20. DOI: 10.1002/1097-0142(196306)16:6<716::aid-cncr2820160605>3.0.co;2-c. View

19.

Goldrosen M . Murine colon adenocarcinoma: immunobiology of metastases. Cancer. 1980; 45(5 Suppl):1223-8. DOI: 10.1002/1097-0142(19800315)45:5+<1223::aid-cncr2820451330>3.0.co;2-f. View

20.

Robinson P, Altevogt P, Schirrmacher V . A mouse hepatocyte carbohydrate-specific receptor and its interaction with liver-metastasizing tumor cells. Int J Cancer. 1983; 32(3):359-66. DOI: 10.1002/ijc.2910320316. View